Anne Prener's most recent trade in Keros Therapeutics Inc was a trade of 14,870 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 14,870 | 14,870 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 13,786 | 13,786 | - | 0 | Common Stock | |
| Galecto Inc | Anne Prener | Director | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | ||
| Galecto Inc | Anne Prener | Director | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | ||
| Galecto Inc | Anne Prener | Director | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | ||
| Galecto Inc | Anne Prener | Director | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) |